Q2 2026 Holdings
Filed 2026-08-14 | 120 holdings | $1.9B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| National Healthcare Corp(NHC) | COM | 635906100 | $4.7M | 22,116 | 0.2% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $4.7M | 69,983 | 0.2% |
| Equillium Inc(EQ) | COM | 29446K106 | $4.9M | 1,520,824 | 0.3% |
| Spdr Series Trust(XBI)Put | ST STR SP BIOT | 78464A870 | $4.9M | 31,000 | 0.3% |
| Pacs Group Inc(PACS) | COM SHS | 69380Q107 | $5.0M | 117,441 | 0.3% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $5.1M | 154,130 | 0.3% |
| National Health Invs Inc(NHI) | COM | 63633D104 | $5.4M | 70,673 | 0.3% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $5.7M | 166,289 | 0.3% |
| LB Pharmaceuticals Inc(LBRX) | COM SHS | 50180M108 | $6.0M | 183,663 | 0.3% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $6.5M | 590,252 | 0.3% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $6.9M | 136,631 | 0.4% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $7.2M | 58,504 | 0.4% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $7.7M | 515,804 | 0.4% |
| Novo-Nordisk A S(NVO) | ADR | 670100205 | $8.1M | 169,227 | 0.4% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $8.1M | 434,314 | 0.4% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $8.4M | 309,689 | 0.4% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $8.6M | 1,678,345 | 0.4% |
| Palisade BIO Inc(PALI) | COM | 696389402 | $8.7M | 4,182,785 | 0.5% |
| Revvity Inc(RVTY) | COM | 714046109 | $9.3M | 83,624 | 0.5% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $9.3M | 275,471 | 0.5% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $9.5M | 672,825 | 0.5% |
| Definium Therapeutics Inc(DFTX) | COM SHS | 24477V105 | $10.2M | 217,185 | 0.5% |
| Insmed Inc(INSM)Call | COM PAR $.01 | 457669307 | $10.3M | 96,600 | 0.5% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $10.5M | 196,302 | 0.5% |
| Moderna Inc(MRNA) | COM | 60770K107 | $10.7M | 152,122 | 0.6% |
| Bruker Corp(BRKR) | COM | 116794108 | $11.0M | 182,894 | 0.6% |
| Ascendis Pharma A/S(ASND) | ORD SHS | K08588103 | $11.1M | 41,621 | 0.6% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $11.2M | 747,994 | 0.6% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $11.9M | 196,532 | 0.6% |
| Humana Inc(HUM) | COM | 444859102 | $12.4M | 31,171 | 0.6% |
| Cytomx Therapeutics Inc.(CTMX) | COM | 23284F105 | $13.3M | 3,558,497 | 0.7% |
| Pharvaris N V(PHVS) | COM | N69605108 | $13.4M | 386,383 | 0.7% |
| Celcuity Inc(CELC) | COM | 15102K100 | $13.4M | 127,931 | 0.7% |
| AMN Healthcare Svcs Inc(AMN) | COM | 001744101 | $13.9M | 428,531 | 0.7% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $14.3M | 249,607 | 0.7% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $15.3M | 831,142 | 0.8% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $15.9M | 149,209 | 0.8% |
| LTC Pptys Inc(LTC) | COM | 502175102 | $16.2M | 420,640 | 0.8% |
| Pennant Group Inc(PNTG) | COM | 70805E109 | $17.0M | 460,272 | 0.9% |
| Molina Healthcare Inc(MOH) | COM | 60855R100 | $18.4M | 80,594 | 1.0% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $18.7M | 1,865,653 | 1.0% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $19.0M | 490,235 | 1.0% |
| Beta Bionics Inc(BBNX) | COM | 08659B102 | $19.6M | 1,249,441 | 1.0% |
| Welltower Inc(WELL) | COM | 95040Q104 | $19.8M | 87,312 | 1.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $21.3M | 51,145 | 1.1% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $21.4M | 114,199 | 1.1% |
| Insulet Corp(PODD) | COM | 45784P101 | $22.7M | 148,816 | 1.2% |
| Omega Healthcare Invs Inc(OHI) | COM | 681936100 | $23.1M | 483,547 | 1.2% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $23.5M | 602,922 | 1.2% |
| Geron Corp(GERN) | COM | 374163103 | $24.0M | 18,717,422 | 1.2% |